These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13533119)

  • 1. [Results with peroral diabetes therapy in tuberculous diabetic patients].
    IRSKENS KJ
    Arztl Wochensch; 1958 Apr; 13(16):346-8. PubMed ID: 13533119
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-treated type 2 diabetes is associated with a decreased survival in heart failure patients after cardiac resynchronization therapy.
    Mangiavacchi M; Gasparini M; Genovese S; Pini D; Klersy C; Bragato R; Andreuzzi B; Municinò A; Regoli F; Galimberti P; Ceriotti C; Gronda E
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1425-32. PubMed ID: 18950300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of tuberculous diabetics with the new peroral antidiabetic agents].
    TICHOLOV K; DOBREV P
    Munch Med Wochenschr; 1959 Feb; 101(7):286-9. PubMed ID: 13644087
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes.
    Vehkavaara S; Yki-Järvinen H
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):325-30. PubMed ID: 14684428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Unusual metabolic disorders in a tuberculous diabetic in severe malnutrition; hypochloremic and hypokalemic alkalosis with acidoketosis].
    PLATTNER HC; DUFOUR JJ
    Presse Med (1893); 1955 May; 63(39):829-31. PubMed ID: 14395149
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
    Römkens TE; Kusters GC; Netea MG; Netten PM
    Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patients.
    Kumar R; Lee TT; Jeremias A; Ruisi CP; Sylvia B; Magallon J; Kirtane AJ; Bigelow B; Abrahamson M; Pinto DS; Ho KK; Cohen DJ; Carrozza JP; Cutlip DE
    Am J Cardiol; 2007 Oct; 100(8):1187-91. PubMed ID: 17920355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DIAB.&TE.S Project: how patients perceive diabetes and diabetes therapy.
    Marra G;
    Acta Biomed; 2004 Dec; 75(3):164-70. PubMed ID: 15796090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):121-6. PubMed ID: 17346952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypoglycemic sulfamides as treatment of diabetic tuberculous patients].
    LOUSTAU-CHARTEZ M; VASSEUR B
    Presse Med (1893); 1958 Jun; 66(45):1022-3. PubMed ID: 13567507
    [No Abstract]   [Full Text] [Related]  

  • 13. Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes.
    Bermúdez V; Cano R; Cano C; Bermúdez F; Leal E; Acosta K; Mengual E; Arraiz N; Briceño C; Gómez J; Bustamante M; Aparicio D; Cabrera M; Valdelamar L; Rodriguez M; Manuel V; Hernández R
    Am J Ther; 2008; 15(4):409-16. PubMed ID: 18645347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient elevation of liver transaminase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwasaki N; Iwamoto Y
    Diabetes Res Clin Pract; 2004 Apr; 64(1):27-32. PubMed ID: 15036824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus.
    Takaike H; Uchigata Y; Iwamoto Y; Imagawa A; Iwahashi H; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Hanafusa T; Makino H
    Ann Med; 2008; 40(5):395-400. PubMed ID: 18484350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin treatment on plasma oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients.
    Galland F; Duvillard L; Petit JM; Lagrost L; Vaillant G; Brun JM; Gambert P; Vergès B
    Diabetes Metab; 2006 Dec; 32(6):625-31. PubMed ID: 17296517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexible intensive insulin therapy in adults with type 1 diabetes and high risk for severe hypoglycemia and diabetic ketoacidosis.
    Sämann A; Mühlhauser I; Bender R; Hunger-Dathe W; Kloos C; Müller UA
    Diabetes Care; 2006 Oct; 29(10):2196-9. PubMed ID: 17003292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications.
    Araszkiewicz A; Zozulinska-Ziolkiewicz D; Trepinska M; Wierusz-Wysocka B
    Diabetes Res Clin Pract; 2008 Jul; 81(1):61-7. PubMed ID: 18378034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy.
    Schmeltz LR; DeSantis AJ; Thiyagarajan V; Schmidt K; O'Shea-Mahler E; Johnson D; Henske J; McCarthy PM; Gleason TG; McGee EC; Molitch ME
    Diabetes Care; 2007 Apr; 30(4):823-8. PubMed ID: 17229943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.